| Sohaib Ansari, MD | |
|
375 Wampanoag Trl, Riverside, RI 02915-2232 | |
| (401) 649-4070 | |
| (401) 649-4071 |
| Full Name | Sohaib Ansari |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Sleep Medicine |
| Location | 375 Wampanoag Trl, Riverside, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437675287 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Sohaib Ansari, MD Dept 3010, Po Box 986524, Boston, MA 02298-6524 Ph: (401) 443-4992 | Sohaib Ansari, MD 375 Wampanoag Trl, Riverside, RI 02915-2232 Ph: (401) 649-4070 |
News Archive
Cardiac marker POC tests are now widely used in hospitals and have emerged as a successful model of the concept of point-of-care diagnostics, according to a new report from Kalorama Information. The 2008 world market for POC cardiac enzymes and tests is estimated at $490 million, and growing at 12% a year for the past three years, according to "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," from healthcare market research publisher Kalorama Information.
Most of us don't think about our teeth and bones until one aches or breaks. A team of engineers at Washington University in St. Louis looked deep within collagen fibers to see how the body forms new bone and teeth, seeking insights into faster bone healing and new biomaterials.
Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials. In addition, Vantia announces results of the successful Phase I trial of VA111913, which showed the product candidate to be safe and well tolerated.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for clinical testing of its patented QL Care™ Analyzer, a portable diagnostic platform designed to produce test results with central lab-like accuracy in 15 minutes using whole blood.
› Verified 3 days ago
Tonslyn Toure, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4090 Fax: 401-649-4091 | |
Jonathan A Leviss, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4020 Fax: 401-649-4021 | |
Thomas D Denucci, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 375 Wampanoag Trl, Suite 202a, Riverside, RI 02915 Phone: 401-649-4030 Fax: 401-649-4031 | |
Kristen Tillquist, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4070 Fax: 401-649-4071 | |
Reginald Y Gohh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 401-649-4060 Fax: 401-649-4061 | |
Dr. Franklin D Mccool, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl Ste 302b, Riverside, RI 02915 Phone: 401-649-4070 Fax: 401-649-4071 | |
Dr. Lewena Maher, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4040 Fax: 401-649-4041 |